The Cardiovascular Effects of Acute and Chronic Hypoglycemia

Cardiol Rev. 2025 Oct 31. doi: 10.1097/CRD.0000000000001114. Online ahead of print.ABSTRACTLarge-scale clinical trials of intensive glycemic control have failed to show cardiovascular benefit, with hypoglycemia implicated as a key factor. Increasing evidence suggests hypoglycemia is not merely a com

A Aparna Dintakurti

Bioresorbable Scaffolds: Ready for a Rematch?

Curr Cardiol Rep. 2026 Feb 3;28(1):18. doi: 10.1007/s11886-025-02291-y.ABSTRACTPURPOSE OF REVIEW: The bioresorbable vascular scaffold (BVS) is a promising technology with clear theoretical benefits. Large randomized controlled trials (RCTs) of the early generation of this technology, however, demons

O Oludamilola Akinmolayemi

DNA Methylation-Guided Prediction and Validation of TAAD Molecular Targets

Biochem Genet. 2026 Feb 3. doi: 10.1007/s10528-026-11324-2. Online ahead of print.ABSTRACTThoracic aortic aneurysms and dissection are pivotal cardiovascular conditions necessitating accurate diagnostics. DNA methylation, a crucial epigenetic mediator, is implicated in early disease biomarkers. Our

M Mengyao Sha